Back to Search
SARAH BERNIER, M.D.
M.D.
Emergency Medicine Physician
NPI: 1083695738IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
224170(MA)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
WRIGHT STATE UNIVERSITY BOONSHOFT SCHOOL OF MEDICINE
Class of 2003
Research & Publications (20)
Methionine aminopeptidases type I and type II are essential to control cell proliferation.
PMID 15962312·J Cell Biochem·2005
8-other
A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis.
PMID 15249666·Proc Natl Acad Sci U S A·2004
7-preclinical
Associate degree nursing programs. Response to the nursing shortage.
PMID 14528738·Nurs Leadersh Forum·2003
8-other
Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase.
PMID 10899167·J Biol Chem·2000
7-preclinical
Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts.
PMID 19528212·Infect Immun·2009
7-preclinical
Cyclic AMP regulates extracellular matrix gene expression and metabolism in cultured primary rat chondrocytes.
PMID 19505573·Matrix Biol·2009
7-preclinical
Egr-1 inhibits the expression of extracellular matrix genes in chondrocytes by TNFalpha-induced MEK/ERK signalling.
PMID 19144181·Arthritis Res Ther·2009
7-preclinical
Kinetic and mechanistic characterization of Mycobacterium tuberculosis glutamyl-tRNA synthetase and determination of its oligomeric structure in solution.
PMID 19187240·FEBS J·2009
8-other
Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists.
PMID 19081720·Bioorg Med Chem Lett·2009
7-preclinical
Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists.
PMID 19282175·Bioorg Med Chem Lett·2009
4-observational
An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis.
PMID 18209961·Inflamm Res·2008
7-preclinical
ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation.
PMID 18269311·J Bone Miner Res·2008
7-preclinical
Regulation of Sox9 activity by crosstalk with nuclear factor-kappaB and retinoic acid receptors.
PMID 18182117·Arthritis Res Ther·2008
7-preclinical
Detection of N-acyl homoserine lactones using a traI-luxCDABE-based biosensor as a high-throughput screening tool.
PMID 18667064·BMC Biotechnol·2008
8-other
Study of subchondral bone adaptations in a rodent surgical model of OA using in vivo micro-computed tomography.
PMID 17900933·Osteoarthritis Cartilage·2008
7-preclinical
A LysR-type transcriptional regulator in Burkholderia cenocepacia influences colony morphology and virulence.
PMID 17967860·Infect Immun·2008
7-preclinical
Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage.
PMID 18023983·Matrix Biol·2008
7-preclinical
P2Y nucleotide receptor signaling through MAPK/ERK is regulated by extracellular matrix: involvement of beta3 integrins.
PMID 17620283·J Cell Physiol·2007
7-preclinical
Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis.
PMID 17968906·Arthritis Rheum·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 363 HIGHLAND AVE
FALL RIVER, MA 02720 - Phone
- (508) 679-3131
Quick Facts
- NPI
- 1083695738
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile